NCT04670094 (Comorbidities) is a clinical trial in Covid19, sponsored by University of Milano Bicocca.

Who is sponsoring NCT04670094?

NCT04670094 is sponsored by University of Milano Bicocca.

Is NCT04670094 still recruiting?

NCT04670094 is currently completed. Last updated 9 November 2022.

Last reviewed 2022-11-09 · How we verify

NCT04670094: Comorbidities

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comorbidities and Risk Score in COVID-19 Patients

Completed Last updated 9 November 2022

What this trial tests

trial in Covid19 in 4,555 participants. Completed in 29 May 2021.

Timeline

30 December 2020

Primary endpoint
29 May 2021

29 May 2021

Quick facts

Lead sponsor	University of Milano Bicocca
Status	Completed
Study type	OBSERVATIONAL
Enrollment	4,555
Start date	30 December 2020
Primary completion	29 May 2021
Estimated completion	29 May 2021
Sites	5 locations across Italy

Conditions studied

Covid19 — all drugs for Covid19 →

Sponsor

University of Milano Bicocca

Who can join

18 and older, any sex, with Covid19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Retrospective multi-center cohort study. Consecutive patients hospitalized for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) up to October 2020 will be included. Patients are followed until discharge from hospital or death.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Negative prognostic impact of electrolyte disorders in patients hospitalized for Covid-19 in a large multicenter study.
Genovesi S, Regolisti G, Rebora P, Occhino G, et al · · 2023 · cited 8× · PMID 36001295 · DOI 10.1007/s40620-022-01429-3
Elevated Serum Urea-to-Creatinine Ratio and In-Hospital Death in Patients with Hyponatremia Hospitalized for COVID-19.
Regolisti G, Rebora P, Occhino G, Lieti G, et al · · 2023 · cited 6× · PMID 37371650 · DOI 10.3390/biomedicines11061555
Incident Atrial Fibrillation and In-Hospital Mortality in SARS-CoV-2 Patients.
Maloberti A, Giannattasio C, Rebora P, Occhino G, et al · · 2022 · cited 6× · PMID 36009487 · DOI 10.3390/biomedicines10081940

Verify or expand the search:

Other recruiting trials for Covid19

Currently open trials in the same condition.

NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting

Other University of Milano Bicocca trials

Trials by the same sponsor.

NCT07257705 — Pilot Trial of a Clinical Decision-Support App for Managing Emergencies Among Clinicians in a Rural Ugandan Hospital · NA · completed
NCT07457138 — Lombard Cohort of Brain Health Services · recruiting
NCT07407608 — ABlative Radiotherapy (for) Unfavorable Prostate Tumors 2.0 · recruiting
NCT07479914 — Art of Memory for Cognitive Enhancement in the Monza Brain Health Service · NA · active not recruiting
NCT07424066 — Non-invasive Vibratory Stimulation of the Knee Muscles for the Improvement of the Somatosensory Input and Motor Performa · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04670094 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Milano Bicocca
Last refreshed: 9 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04670094.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing